Maartens G - Search Results

1

The Cape Town Clinical Decision Rule for Streptococcal Pharyngitis in Children.

Engel ME, Cohen K, Gounden R, Kengne AP, Barth DD, Whitelaw AC, Francis V, Badri M, Stewart A, Dale JB, Mayosi BM, Maartens G. Engel ME, et al. Among authors: maartens g. Pediatr Infect Dis J. 2017 Mar;36(3):250-255. doi: 10.1097/INF.0000000000001413. Pediatr Infect Dis J. 2017. PMID: 27870815 Free PMC article.

2

Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area.

Badri M, Ehrlich R, Wood R, Pulerwitz T, Maartens G. Badri M, et al. Among authors: maartens g. Int J Tuberc Lung Dis. 2001 Mar;5(3):225-32. Int J Tuberc Lung Dis. 2001. PMID: 11326821

3

Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations.

Badri M, Ehrlich R, Wood R, Maartens G. Badri M, et al. Among authors: maartens g. AIDS. 2001 Jun 15;15(9):1143-8. doi: 10.1097/00002030-200106150-00009. AIDS. 2001. PMID: 11416716

4

AIDS in Africa--survival according to AIDS-defining illness.

Post FA, Badri M, Wood R, Maartens G. Post FA, et al. Among authors: maartens g. S Afr Med J. 2001 Jul;91(7):583-6. S Afr Med J. 2001. PMID: 11544975

5

Antiretroviral therapy and drug interactions.

Cohen K, Andrews S, Maartens G. Cohen K, et al. Among authors: maartens g. S Afr Med J. 2001 Oct;91(10):816-9. S Afr Med J. 2001. PMID: 11732449 Review. No abstract available.

6

Predictors and prognostic value of oral hairy leukoplakia and oral candidiasis in South African HIV-infected patients.

Badri M, Maartens G, Wood R. Badri M, et al. Among authors: maartens g. SADJ. 2001 Dec;56(12):592-6. SADJ. 2001. PMID: 11887444

7

Tuberculosis should not be considered an AIDS-defining illness in areas with a high tuberculosis prevalence.

Badri M, Ehrlich R, Pulerwitz T, Wood R, Maartens G. Badri M, et al. Among authors: maartens g. Int J Tuberc Lung Dis. 2002 Mar;6(3):231-7. Int J Tuberc Lung Dis. 2002. PMID: 11934141

8

Cost-effectiveness of highly active antiretroviral therapy in South Africa.

Badri M, Maartens G, Mandalia S, Bekker LG, Penrod JR, Platt RW, Wood R, Beck EJ. Badri M, et al. Among authors: maartens g. PLoS Med. 2006 Jan;3(1):e4. doi: 10.1371/journal.pmed.0030004. Epub 2005 Dec 6. PLoS Med. 2006. PMID: 16318413 Free PMC article.

9

Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry.

Mayosi BM, Wiysonge CS, Ntsekhe M, Volmink JA, Gumedze F, Maartens G, Aje A, Thomas BM, Thomas KM, Awotedu AA, Thembela B, Mntla P, Maritz F, Blackett KN, Nkouonlack DC, Burch VC, Rebe K, Parish A, Sliwa K, Vezi BZ, Alam N, Brown BG, Gould T, Visser T, Shey MS, Magula NP, Commerford PJ. Mayosi BM, et al. Among authors: maartens g. BMC Infect Dis. 2006 Jan 6;6:2. doi: 10.1186/1471-2334-6-2. BMC Infect Dis. 2006. PMID: 16396690 Free PMC article.

10

When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.

Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, Orrell C, Wood R. Badri M, et al. Among authors: maartens g. Antivir Ther. 2006;11(1):63-72. Antivir Ther. 2006. PMID: 16518961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

396 results

Search Page